Progress towards elimination goals for viral hepatitis

被引:138
作者
Cox, Andrea L. [1 ]
El-Sayed, Manal H. [2 ]
Kao, Jia-Horng [3 ,4 ]
Lazarus, Jeffrey V. [5 ]
Lemoine, Maud [6 ]
Lok, Anna S. [7 ]
Zoulim, Fabien [8 ,9 ,10 ]
机构
[1] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA
[2] Ain Shams Univ, Dept Paediat, Cairo, Egypt
[3] Natl Taiwan Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Taipei, Taiwan
[4] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan
[5] Univ Barcelona, Barcelona Inst Global Hlth ISGlobal, Hosp Clin, Barcelona, Spain
[6] Imperial Coll London, St Marys Hosp, Dept Metab Digest & Reprod, Div Digest Dis,Hepatol Sect, London, England
[7] Univ Michigan, Dept Internal Med, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA
[8] Lyon Univ, Med Sch, Lyon, France
[9] Hosp Civils Lyon, Hepatol Dept, Lyon, France
[10] INSERM, CRCL, U1052, Viral Hepatitis Res Lab, Lyon, France
关键词
B-VIRUS INFECTION; C-VIRUS; GLOBAL ELIMINATION; CHALLENGES; DISEASE; TAIWAN;
D O I
10.1038/s41575-020-0332-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The global burden of viral hepatitis is substantial; in terms of mortality, hepatitis B virus and hepatitis C virus infections are on a par with HIV, malaria and tuberculosis, among the top four global infectious diseases. In 2016, the 194 Member States of the World Health Organization committed to eliminating viral hepatitis as a public health threat by 2030, with a particular focus on hepatitis B virus and hepatitis C virus infection. With only 10 years to go until the 2030 deadline is reached, and although much progress has been made towards elimination, there are still some important gaps in terms of policy and progress. In this Viewpoint, we asked a selection of scientists and clinicians working in the viral hepatitis field for their opinions on whether elimination of viral hepatitis by 2030 is feasible, what the key areas of progress are and what the focus for the next 10 years and beyond should be for viral hepatitis elimination.
引用
收藏
页码:533 / 542
页数:10
相关论文
共 66 条
  • [1] [Anonymous], 2013, Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach
  • [2] Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia
    Averhoff, Francisco
    Shadaker, Shaun
    Gamkrelidze, Amiran
    Kuchuloria, Tatia
    Gvinjilia, Lia
    Getia, Vladimer
    Sergeenko, David
    Butsashvili, Maia
    Tsertsvadze, Tengiz
    Sharvadze, Lali
    Zarkua, Jaba
    Skaggs, Beth
    Nasrullah, Muazzam
    [J]. JOURNAL OF HEPATOLOGY, 2020, 72 (04) : 680 - 687
  • [3] Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
    Bartenschlager, Ralf
    Baumert, Thomas F.
    Bukh, Jens
    Houghton, Michael
    Lemon, Stanley M.
    Lindenbach, Brett D.
    Lohmann, Volker
    Moradpour, Darius
    Pietschmann, Thomas
    Rice, Charles M.
    Thimme, Robert
    Wakita, Takaji
    [J]. VIRUS RESEARCH, 2018, 248 : 53 - 62
  • [4] Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry
    Belli, Luca Saverio
    Perricone, Giovanni
    Adam, Rene
    Cortesi, Paolo A.
    Strazzabosco, Mario
    Facchetti, Rita
    Karam, Vincent
    Salizzoni, Mauro
    Andujar, Rafael Lopez
    Fondevila, Costantino
    De Simone, Paolo
    Morelli, Cristina
    Fabregat-Prous, Joan
    Samuel, Didier
    Agarwaal, Kosh
    Gonzales, Enrique Moreno
    Charco, Ramon
    Zieniewicz, Krzysztof
    De Carlis, Luciano
    Duvoux, Christophe
    [J]. JOURNAL OF HEPATOLOGY, 2018, 69 (04) : 810 - 817
  • [5] The epidemiology of hepatitis delta virus infection in Cameroon
    Besombes, Camille
    Njouom, Richard
    Paireau, Juliette
    Lachenal, Guillaume
    Texier, Gaetan
    Tejiokem, Mathurin
    Cauchemez, Simon
    Pepin, Jacques
    Fontanet, Arnaud
    [J]. GUT, 2020, 69 (07) : 1294 - 1300
  • [6] Taiwan commits to eliminating hepatitis C in 2025
    Chen, Ding-Shinn
    [J]. LANCET INFECTIOUS DISEASES, 2019, 19 (05) : 466 - 467
  • [7] Fighting Against Viral Hepatitis: Lessons from Taiwan
    Chen, Ding-Shinn
    [J]. HEPATOLOGY, 2011, 54 (02) : 381 - 392
  • [8] Coalition for Global Hepatitis Elimination, 2019, HEP PREV CONTR EL MO
  • [9] Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
    Cooke, Graham S.
    Andrieux-Meyer, Isabelle
    Applegate, Tanya L.
    Atun, Rifat
    Burry, Jessica R.
    Cheinquer, Hugo
    Dusheiko, Geoff
    Feld, Jordan J.
    Gore, Charles
    Griswold, Max G.
    Hamid, Saeed
    Hellard, Margaret E.
    Hou, JinLin
    Howell, Jess
    Jia, Jidong
    Kravchenko, Natalia
    Lazarus, Jeffrey V.
    Lemoine, Maud
    Lesi, Olufunmilayo A.
    Maistat, Liudmyla
    McMahon, Brian J.
    Razavi, Homie
    Roberts, Teri R.
    Simmons, Bryony
    Sonderup, Mark W.
    Spearman, C. Wendy
    Taylor, Bridie E.
    Thomas, David L.
    Waked, Imam
    Ward, John W.
    Wiktor, Stefan Z.
    Abdo, Ayman
    Aggarwal, Rakesh
    Aghemo, Alessio
    Al-Judaibi, Bandar
    Al Mahtab, Mamun
    Altaf, Arshad
    Ameen, Zyaad
    Asselah, Tarik
    Baatarkkhuu, Oidov
    Barber, Ella
    Barnes, Eleanor
    Boulet, Pascale
    Burrows, Louise
    Butsashvili, Maia
    Chan, Erica
    Chow, Chelsea
    Cowie, Ben
    Cunningham, Chris
    de Araujo, Alexandre
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (02): : 135 - 184
  • [10] Cornberg M, 2020, HEPATOLOGY, V71, P1070, DOI [10.1002/hep.31030, 10.1016/j.jhep.2019.11.003]